CIK 0001534133 · Non-accelerated filer<br>Smaller reporting company
CalciMedica, Inc.
Sign in to watch- Ticker
- CALC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452120079
- Phone
- 858-952-5500
- Business address
- 505 COAST BOULEVARD SOUTH, SUITE 307, LA JOLLA, CA, 92037
- Former names
- CalciMedica, Inc. /DE/, GRAYBUG VISION, INC., GRAYBUG, Inc., GRAYBUG LLC
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13D Stake Beneficial Ownership Report
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- SCHEDULE 13D Stake Beneficial Ownership Report
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 248,972 shares at $0.80 ($199,999)
- 4 Grant or award Chief Medical Officer acquired 124,486 shares (grant or award)
- 4 Grant or award Director acquired 1,182,621 shares (grant or award)
- 4 Grant or award CHIEF BUSINESS OFFICER acquired 186,729 shares (grant or award)
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 186,729 shares (grant or award)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure · Other events
- 8-K Event Material agreement · Unregistered share sale
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 3 of 27 · 533 filings